Interceptor Plus (milbemycin oxime/praziquantel) is an FDA-approved, prescription monthly chewable tablet that protects dogs against five worm categories: heartworm, hookworm, roundworm, whipworm, and tapeworm. It is one of the few oral heartworm preventives that includes tapeworm coverage, which is the main reason veterinarians choose it over ivermectin-based alternatives like Heartgard Plus.

This article explains what each active ingredient covers, what the FDA label says, safety considerations including the MDR1 gene question, and how Interceptor Plus fits into the broader heartworm prevention landscape.

What Interceptor Plus covers

Interceptor Plus is labeled for five parasite categories in dogs and puppies 6 weeks of age and older weighing at least 2 lb:

The combination of praziquantel with milbemycin oxime gives Interceptor Plus the broadest intestinal worm spectrum among standalone oral heartworm preventives. Tapeworm coverage (four species) and whipworm coverage are the two categories that separate it from ivermectin-based products.

The two active ingredients and how they work

Milbemycin oxime

Milbemycin oxime is a macrocyclic lactone (the same drug class as ivermectin and moxidectin). In Interceptor Plus, it handles:

• Heartworm prevention: Kills the tissue-stage larvae (L3 and L4) of Dirofilaria immitis before they develop into adult heartworms. In a controlled laboratory study, milbemycin oxime was 100% effective against induced heartworm infections when administered monthly for six consecutive months.
• Roundworm, hookworm, and whipworm treatment and control: Kills adult stages of these intestinal nematodes.

Milbemycin oxime is the same active ingredient that was in the original Interceptor (discontinued in 2013 and re-launched), as well as Sentinel, Trifexis, and Sentinel Spectrum. It has been used in veterinary medicine since the 1990s.

Praziquantel

Praziquantel is an isoquinolone anthelmintic that has demonstrated 100% efficacy in controlled studies against four species of adult tapeworms. It works by damaging the tapeworm's tegument (outer surface), causing paralysis and detachment from the intestinal wall.

The praziquantel component is what makes Interceptor Plus distinct from plain milbemycin oxime products and from ivermectin-based heartworm preventives, none of which cover tapeworms on their own.

Dosing and administration

Per the FDA label (NADA 141-338) and Elanco product information:

• Frequency: Once monthly, orally
• Minimum dose: 0.23 mg/lb (0.5 mg/kg) milbemycin oxime and 2.28 mg/lb (5 mg/kg) praziquantel
• Must be given with food for optimal absorption
• If a dose is missed: Give immediately and resume monthly schedule
• Heartworm testing: Dogs should be tested for existing heartworm infection before starting Interceptor Plus, as the product is not effective against adult heartworms

Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention.

Safety profile

General safety

The FDA label lists the following adverse reactions reported in dogs after administration of milbemycin oxime or praziquantel: vomiting, diarrhea, depression/lethargy, ataxia, anorexia, convulsions, weakness, and salivation.

Safety studies demonstrated that Interceptor Plus was well tolerated at up to 5 times the maximum labeled dose in 8-week-old puppies.

MDR1 gene mutation (herding breeds)

Milbemycin oxime, like ivermectin, is a substrate of P-glycoprotein. Dogs with the MDR1 (ABCB1) gene mutation — most commonly Collies, Australian Shepherds, Shelties, and other herding breeds — may have increased sensitivity to macrocyclic lactones at elevated doses.

However, at the labeled heartworm-prevention dose, milbemycin oxime has been shown to be safe in MDR1-affected dogs. This is a dose-dependent issue: the heartworm preventive dose is far below the threshold where MDR1-related toxicity occurs. Veterinarians generally consider milbemycin oxime products safe at labeled doses even in MDR1-positive dogs, but the standard precaution is to discuss MDR1 testing with your veterinarian if you own a herding breed.

Breeding, pregnant, and lactating dogs

The safety of Interceptor Plus has not been evaluated in dogs used for breeding or in lactating females. The label does not prohibit use in these animals but recommends veterinary consultation.

Heartworm-positive dogs

Dogs should be tested for existing heartworm infection before starting any heartworm preventive, including Interceptor Plus. Administering a heartworm preventive to a dog with an active adult heartworm infection can cause a rapid die-off of microfilariae, potentially triggering a hypersensitivity reaction (including shock). Dogs with high microfilariae counts are at greatest risk. This is a class-wide precaution for all macrocyclic lactone heartworm preventives, not specific to Interceptor Plus.

Interceptor Plus vs Heartgard Plus: the key differences

Both products are monthly oral heartworm preventives, but they differ in active ingredients and parasite spectrum.

The two practical differences that drive the choice:

1. Tapeworm and whipworm coverage. Interceptor Plus covers both; Heartgard Plus covers neither. If your dog has recurrent tapeworm exposure (flea ingestion, hunting, rural environments) or whipworm risk, Interceptor Plus covers these in a single product without requiring a separate dewormer.
2. Ingredient tolerance. Some dogs that experience gastrointestinal upset on ivermectin-based products tolerate milbemycin oxime better, and vice versa. If your dog vomits or has diarrhea on one product, switching to the other active ingredient class is a reasonable discussion to have with your veterinarian.

Neither product covers fleas, ticks, or mites. Both require a separate flea/tick preventive if ectoparasite protection is needed.

What Interceptor Plus does not cover

It is important to understand the gaps:

• Fleas and ticks: No ectoparasite coverage. A separate flea/tick product (such as a combination isoxazoline preventive like Simparica Trio, NexGard PLUS, or Credelio Quattro) is needed for flea and tick protection.
• Adult heartworms: Interceptor Plus prevents heartworm disease by killing larval stages. It does not treat existing adult heartworm infections. A positive heartworm test requires a different treatment protocol managed by a veterinarian.
• Not all hookworm species equally: The label covers Ancylostoma caninum but not Ancylostoma braziliense or Uncinaria stenocephala (covered by some competing products).
• Resistance: Heartworm resistance to macrocyclic lactones has been documented, though it remains uncommon. CAPC recommends year-round prevention and annual testing regardless of which preventive is used.

When veterinarians choose Interceptor Plus

Common scenarios where Interceptor Plus is the preferred heartworm preventive:

• Dogs with tapeworm history. The praziquantel component treats Dipylidium caninum (flea tapeworm), Taenia species, and Echinococcus species without requiring a separate dewormer.
• Dogs on a non-combination flea/tick product. If a dog takes Bravecto, Credelio, or Simparica (standalone) for fleas and ticks, Interceptor Plus fills the heartworm and intestinal worm gap without adding another isoxazoline.
• Households with small children. Roundworm and hookworm are zoonotic. Monthly treatment with Interceptor Plus reduces environmental egg shedding.
• Dogs that did not tolerate ivermectin. Switching to milbemycin oxime is a reasonable alternative for dogs with GI sensitivity to Heartgard Plus.

Pairing Interceptor Plus with a flea and tick product

Interceptor Plus has no ectoparasite activity. Dogs taking it need a separate flea and tick preventive if they have any ectoparasite exposure. Common pairings veterinarians use:

• Standalone isoxazoline chew (Credelio, Bravecto, Simparica, NexGard) — these cover fleas and ticks but not heartworm or most intestinal worms, so they pair naturally with Interceptor Plus.
• Topical spot-ons (Frontline, Advantage, K9 Advantix) — also commonly paired with Interceptor Plus for dogs that do not tolerate oral flea/tick medications.

The key principle: Interceptor Plus handles internal parasites (heartworm, roundworm, hookworm, whipworm, tapeworm). The flea/tick product handles external parasites. There is no ingredient overlap or interaction concern between milbemycin oxime/praziquantel and the isoxazoline or fipronil/imidacloprid classes used in flea/tick products.

If you are switching from a combination product (like Simparica Trio or NexGard PLUS) to Interceptor Plus plus a standalone flea/tick product, give the first Interceptor Plus dose within one month of the last combination dose to maintain continuous heartworm coverage.

Sources

• Elanco. Interceptor Plus product label and prescribing information. NADA 141-338. https://my.elanco.com/us/interceptor-plus
• FDA Freedom of Information Summary. NADA 141-338 Supplement (June 21, 2017). Addition of Dipylidium caninum tapeworm claim. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1504
• DailyMed. Interceptor Plus (milbemycin oxime/praziquantel) chewable tablets. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=86b367e3-64e5-4c44-9961-6caea5d12e75
• Veterinary Partner / VIN. "Heartworm Preventive Comparison Chart for Dogs and Cats." https://veterinarypartner.vin.com/doc/?id=4951375
• Companion Animal Parasite Council (CAPC). Heartworm guidelines. https://capcvet.org/guidelines/heartworm/
• Mar Vista Animal Medical Center. "Heartworm Comparison." https://www.marvistavet.com/heartworm-comparison.pml